Location History:
- Osaka, JP (2000)
- Hyogo, JP (2007)
Company Filing History:
Years Active: 2000-2007
Title: Munetada Haruyama: Innovator in Hematopoietic Stem Cell Research
Introduction
Munetada Haruyama is a notable inventor based in Hyogo, Japan. He has made significant contributions to the field of hematopoietic stem cell research, holding a total of 2 patents. His work focuses on developing therapeutics that address critical health issues related to blood cell production.
Latest Patents
One of his latest patents is titled "Methods of promoting the growth or differentiation of hematopoietic stem or progenitor cells by non-muscle type cofilin." This invention aims to provide promoters that enhance the growth and differentiation of hematopoietic stem cells and progenitors. These promoters are particularly useful in treating diseases caused by insufficient growth or differentiation of these cells, such as panhematopenia and conditions associated with hematopoietic hypofunction. The invention utilizes Cofilin as an active ingredient to achieve its therapeutic objectives. Another significant patent focuses on "Therapeutics for thrombocytopenia," which addresses the need for effective treatments in this area.
Career Highlights
Throughout his career, Munetada Haruyama has worked with prominent companies, including Asubio Pharma Co. Ltd. and Suntory Limited. His experience in these organizations has contributed to his expertise in the development of innovative therapeutic solutions.
Collaborations
He has collaborated with notable colleagues such as Kenju Miura and Shiho Kodama, further enhancing the impact of his research and inventions.
Conclusion
Munetada Haruyama's contributions to hematopoietic stem cell research and his innovative patents highlight his role as a key figure in the field. His work continues to pave the way for advancements in therapeutic treatments for critical health conditions.